Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Scam alert: Beware of emails impersonating MOH that request for a mandatory “Digital Health Verification”.


MOH does not own this portal and will only request verification via official channels. If in doubt, call the MOH hotline at 6325 9220 to verify the email’s authenticity.

Ministry of Health
Parliamentary QA

CRITERIA FOR SELECTION OF CONDITIONS FOR SUBSIDISED GENETIC TESTING

3 November 2026

NOTICE PAPER NO. 1500

NOTICE OF QUESTION FOR ORAL ANSWER

FOR THE SITTING OF PARLIAMENT ON 3 NOVEMBER 2026

 

Name and Constituency of Member of Parliament

Ms Joan Pereira

MP for Tanjong Pagar GRC


Question No. 3285

To ask the Coordinating Minister for Social Policies and Minister for Health (a) what criteria will guide its selection of conditions for subsidised genetic testing, including clinical effectiveness, cost-effectiveness and the availability of preventive interventions; and (b) whether the Ministry will consider subsidising for more hereditary conditions for which early detection and timely intervention can prevent disease or reduce its severity.


Answer

1            Clinical and cost effectiveness will be the key considerations in determining whether to implement and subsidise genetic testing for a particular condition. We need to ensure that the test meaningfully informs clinical management, and through early detection and intervention, improves health outcomes downstream. This is important given the vast potential and possibilities of genetic testing.  Based on these criteria, the Ministry of Health subsidised genetic testing for Familial Hypercholesterolemia since last year, will be doing so for Hereditary Breast and Ovarian Cancer from later this year, and will continue to evaluate potential use cases according to the same criteria.